This page includes the latest FDA filings for Kala Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | KALA | DUNS 833269470 |
Device Company | Device | Date |
|---|---|---|
| ALCON LABORATORIES, INC. | Prescription Medication | 2024-04-02 |
| ALCON LABORATORIES, INC. | Prescription Medication | 2024-03-31 |
| ALCON LABORATORIES, INC. | Prescription Medication | 2023-12-15 |
| ALCON LABORATORIES, INC. | Prescription Medication | 2023-12-15 |
| ALCON LABORATORIES, INC. | Prescription Medication | 2022-07-14 |
| ALCON LABORATORIES, INC. | Prescription Medication | 2022-07-14 |
| ALCON LABORATORIES, INC. | Prescription Medication | 2022-07-02 |
| ALCON LABORATORIES, INC. | Prescription Medication | 2022-07-02 |
| ALCON LABORATORIES, INC. | Prescription Medication | 2021-07-15 |
| ALCON LABORATORIES, INC. | Prescription Medication | 2021-07-15 |
| ALCON LABORATORIES, INC. | Prescription Medication | 2020-11-19 |
| Kala Pharmaceuticals, Inc. | Eysuvis | 2020-11-18 |
| ALCON LABORATORIES, INC. | Prescription Medication | 2020-05-09 |
| ALCON LABORATORIES, INC. | Prescription Medication | 2018-09-01 |
| Kala Pharmaceuticals, Inc. | Inveltys | 2018-08-22 |
| NCAGE Code | 5VRP4 | KALA PHARMACEUTICALS, INC.!DBA KALA |
| CAGE Code | 5VRP4 | KALA PHARMACEUTICALS, INC. KALA |
| S.A.M. Registration | 5VRP4 [833269470] | KALA PHARMACEUTICALS, INC. KALA |
| SEC | 0001479419 | Kala Pharmaceuticals, Inc. of DELAWARE |